Les Nanomédicaments: des médicaments plus efficace et moins toxique (a Nano World Cancer Day presentation)

Bowl of Hygieia. Olomouc, CZ. Michal Maňas CCA-SA 2.5

Nanobiotix - in an ETNP partnership with the CLARA Cancer Research Cluster (Cancéropôle Lyon Auvergne Rhône-Alpes) - organised the Nano- prelude to World Cancer Day. Slides and texts of the Conference's NanoMedicine-themed webcast (from Friday 1 February 2013) are now viewable.


Dr. Amaury Martin's (Secretary General, CLARA) conference component includes considerations re dangers of novel products and risk behaviours.


          Dr. Laurent Lévy (Vice-Chair, ETPN; CEO, Nanobiotix) highlights the significant differentiating impact of radio-enhancing nano-modalities in oncological treatments - including expected decreased toxicity and improved efficiencies.



Pr. Dr. Bo Lu (Radio-Oncology|Molecular Biology|Translational Research, Thomas Jefferson University) discusses amelioration and reduction of therapy-related toxicities in the context of radiation/chemotherapy limitations and anticipated patient outcomes during on-going NanoXRay clinical trials.  In his component, Dr Lu proposes the possibility of combined nano-radio-immunotherapy applications -  a novel strategy still in the proof-of-concept phase.


Pr. Elias Fattal's (CNRS-UMR, Institut Galien Paris-Sud, Université Paris Sud, UFR de Pharmacie) toxicology segment encompasses issues surrounding innovative efficiency while emphasising reduced toxicity of an inherent safe-by-design nano-drug development approach.

Disclosure: LLP holds no financial position nor possesses any vested interest in Nanobiotix SA (NANO:FP).

Views: 129


You need to be a member of The International NanoScience Community to add comments!

Join The International NanoScience Community

Welcome - about us

Welcome! Nanopaprika was cooked up by Hungarian chemistry PhD student in 2007. The main idea was to create something more personal than the other nano networks already on the Internet. Community is open to everyone from post-doctorial researchers and professors to students everywhere.

There is only one important assumption: you have to be interested in nano!

Nanopaprika is always looking for new partners, if you have any idea, contact me at editor@nanopaprika.eu

Dr. András Paszternák, founder of Nanopaprika

Partner network:

Next partner events of TINC

We are Media Partner of:



© 2019   Created by András Paszternák, PhD (founder).   Powered by

Badges  |  Report an Issue  |  Terms of Service